𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson's disease

✍ Scribed by Lena Kertelge; Norbert Brüggemann; Alexander Schmidt; Vera Tadic; Claudia Wisse; Sylwia Dankert; Laura Drude; Joyce van der Vegt; Hartwig Siebner; Heike Pawlack; Peter P. Pramstaller; Maria Isabel Behrens; Alfredo Ramirez; Dirk Reichel; Carsten Buhmann; Johann Hagenah; Christine Klein; Katja Lohmann; Meike Kasten

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
645 KB
Volume
25
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Olfaction is typically impaired in idiopathic Parkinson's disease (IPD), but its role is uncertain in monogenic PD. Diminished color discrimination has been suggested as another early sign of dopaminergic dysfunction but not been systematically studied. Furthermore, it is unknown whether both deficits are linked. We examined 100 patients with IPD, 27 manifesting mutation carriers (MC), 20 nonmanifesting mutation carriers (NMC), and 110 controls. Participants underwent a standardized neurological examination, the University of Pennsylvania Smell Identification Test (UPSIT), the Farnsworth‐Munsell (FM) color discrimination test, and mutation testing in known PD genes. The monogenic group consisted of 15 Parkin (6MC/9NMC), 17 PINK1 (10MC/7NMC), 8 LRRK2 (4MC/4NMC), 3 SNCA (MC), and 4 ATP13A2 (MC) carriers. Olfaction was most impaired in IPD (UPSIT percentiles 10.1 ± 13.5) compared with all other groups (MC 13.8 ± 11.9, NMC 19.6 ± 13.0, controls 33.8 ± 22.4). Within MC, carriers of two mutations in Parkin and PINK1 showed higher UPSIT percentiles than LRRK2 and SNCA carriers. Color discrimination was reduced in IPD (FM total error score 134.8 ± 92.7). In MC (122.4 ± 142.4), the reduction was most pronounced in LRRK2, NMC (80.0 ± 38.8) were comparable with controls (97.2 ± 61.1). UPSIT and FM scores were correlated in the control (r = −0.305; P = 0.002) and the IPD group (r = −0.303; P = 0.006) but not among mutation carriers. First, we confirmed olfaction and color discrimination to be impaired in IPD and suggest olfaction to be a premotor sign. Second, olfaction differed between carriers with one and two mutations in Parkin/PINK1‐associated PD. Third, olfaction and color discrimination impairment do not necessarily evolve in parallel. © 2010 Movement Disorder Society

📜 SIMILAR VOLUMES

Risk factors for Parkinson's disease and
Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease
✍ Andrew Siderowf; Danna Jennings; James Connolly; Richard L. Doty; Kenneth Marek; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Abstract Our objective was to assess the association between risk factors for Parkinson's disease (PD) and abnormal olfaction in first‐degree relatives of patients with PD. Factors including lower cigarette smoking and lower caffeine consumption have been associated with increased risk of PD. Id

Rating impairment and disability in Park
Rating impairment and disability in Parkinson's disease: Evaluation of the unified Parkinson's disease rating scale
✍ Dr. J. J. van Hilten; A. D. van der Zwan; A. H. Zwinderman; R. A. C. Roos 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB 👁 1 views

## Abstract Although the Unified Parkinson's Disease Rating Scale (UPDRS) is widely used to monitor disease progression and drug efficacy, no attempts have been made to evaluate its scientific and clinical quality. Poor clinical sensibility of items in the activities of daily living (ADL) section a

Alterations of the sense of self and per
Alterations of the sense of self and personality in Parkinson's disease
✍ Patrick McNamara; Raymon Durso; Erica Harris 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

## Abstract ## Purpose We hypothesized that alterations of subcomponents (‘harm‐avoidance’) of personality and the sense of Self in patients with PD would be associated with executive cognitive dysfunction. ## Methods Thirty‐four patients with PD and 17 age‐matched controls with chronic disease

Neuroanatomical substrate of visuospatia
Neuroanatomical substrate of visuospatial and visuoperceptual impairment in Parkinson's disease
✍ Joana B. Pereira; Carme Junqué; María-Jośe Martí; Blanca Ramirez-Ruiz; Nuria Bar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

## Abstract To determine magnetic resonance imaging patterns of gray matter (GM) atrophy underlying visuospatial and visuoperceptual impairment in Parkinson's disease (PD), we applied voxel‐based morphometry to 36 nondemented PD patients and correlated their whole brain GM density with performance